Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Prospective Evaluation of Potential Effects of Repeated Gadolinium-based Contrast Agent (GBCA) Administrations of the Same GBCA on Motor and Cognitive Functions in Neurologically Normal Adults in Comparison to a Non-GBCA Exposed Control Group

NCT04373564 is registered in ClinicalTrials.gov with Guerbet as lead sponsor.

NCT NCT04373564
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04373564 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Prospective Evaluation of Potential Effects of Repeated Gadolinium-based Contrast Agent (GBCA) Administrations of the Same GBCA on Motor and Cognitive Functions in Neurologically Normal Adults in Comparison to a Non-GBCA Exposed Control Group
Lead sponsor
Guerbet
Phase
Phase 4
Overall status
Recruiting
Start date
March 24, 2021
Completion date
December 31, 2028
Enrollment
2,076 (estimated)
Sites
51

Conditions

As the registry lists them; a condition with its own page is linked.

cognitive function, contrast media, motor function